AI assistant
IMMUNIC, INC. — Director's Dealing 2014
Oct 9, 2014
10196_dirs_2014-10-09_e8191d41-7d52-4629-b6ac-65322697bd4b.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: VITAL THERAPIES INC (VTL)
CIK: 0001280776
Period of Report: 2014-10-08
Reporting Person: Satter Muneer A (Director, 10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2014-10-08 | Common Stock | P | 74286 | $17.50 | Acquired | 6732277 | Indirect |
Footnotes
F1: All shares were purchased in connection with the Issuer's registered public offering of common stock.
F2: Includes (a) 4,202,930 shares that are held by Muneer A. Satter Revocable Trust for which the Reporting Person serves as trustee and, in such capacity, has sole voting and dispositive power over all such shares and (b) 2,529,347 shares that are held by various other trusts and other entities for which the Reporting Person serves as trustee, investment advisor or manager and, in such capacity, has sole voting and dispositive power over all such shares. The Reporting Person disclaims beneficial ownership of all shares included in clause (b) of this footnote (2), except to the extent of his pecuniary interest.